Keros Therapeutics, Inc. (KROS) Capital expenditures 2019–2025
Keros Therapeutics, Inc. (KROS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.6MFY2025 · since FY2019: $271,000 → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | -19.7% |
| FY2024 | $1.9M | -21.6% |
| FY2023 | $2.5M | +98.5% |
| FY2022 | $1.2M | +21.2% |
| FY2021 | $1.0M | +248.3% |
| FY2020 | $294,000 | +8.5% |
| FY2019 | $271,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice